Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:34:57 EDT Tue 22 Oct 2024
Enter Symbol
or Name
USA
CA



T:HLS - HLS THERAPEUTICS INC. J - http://www.hlstherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HLS - T  1.03.75·3.980.53.86-0.04-1.016.558793.89  3.94  3.705.48  3.00Oct 21Aug 2815 min RT 2¢
TSX - T1.03.75·3.980.53.86-0.04-1.011.541383.89  3.94  3.705.48  3.00Oct 2115 min
Alpha - A 3.93+0.030.80.7263.92  3.94  3.92Oct 2115 min
Omega - O 3.73-0.17-4.41.4533.73  3.73  3.73Oct 2115 min
Chi-X - X 3.83-0.07-1.80.6263.94  3.94  3.83Oct 2115 min
CX2 - H 3.900.0011    Oct 1815 min
CXD - D 3.81-0.09-2.30.1013.81  3.81  3.81Oct 2115 min
TriAct - M 3.902.2724    Sep 11/2015 min

Recent Trades - Last 10 of 79
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:53M3.75-0.15179 CIBC79 CIBCE
15:59:50T3.86-0.0410079 CIBC79 CIBCK
15:59:46M3.86-0.0410079 CIBC79 CIBC
15:59:43T3.81-0.0910079 CIBC79 CIBCK
15:59:39T3.82-0.0810079 CIBC79 CIBCK
15:59:36M3.87-0.0310079 CIBC79 CIBC
15:59:32T3.82-0.0810079 CIBC79 CIBCK
15:59:29M3.87-0.0310079 CIBC79 CIBC
15:59:25M3.87-0.0310079 CIBC79 CIBC
15:59:22M3.87-0.0310079 CIBC79 CIBC

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-08-08 07:17C:HLS3.05SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-08-08 07:17C:HLS3.05SEDAR Interim MD & ASEDAR Interim MD & A
2024-08-08 06:30C:HLS3.05News ReleaseHLS Therapeutics Announces Q2 2024 Financial Results
2024-07-29 11:35C:HLS3.35News ReleaseHLS Therapeutics lists Vascepa under Alberta drug plan
2024-07-25 09:01C:HLS3.24News ReleaseHLS Therapeutics to release Q2 2024 results Aug. 8
2024-07-02 11:20C:HLS3.35News ReleaseHLS Therapeutics sells Xenpozyme royalty interest
2024-06-07 19:10C:HLS3.65News ReleaseHLS Therapeutics shareholders elect eight directors
2024-05-28 10:45C:HLS3.70News ReleaseHLS talks PSPs, clozapine treatment study results
2024-05-09 11:00C:HLS4.15News ReleaseHLS Therapeutics loses $6.1-million (U.S.) in Q1 2024
2024-05-09 07:20C:HLS4.78SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-09 07:20C:HLS4.78SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-25 12:42C:HLS4.75News ReleaseHLS to release fiscal Q1 2024 results May 9
2024-04-08 10:27C:HLS5.04News ReleaseHLS Therapeutics touts Vascepa for MACE reduction
2024-03-14 16:06C:HLSSEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-14 12:11C:HLS4.34SEDAR MD & ASEDAR MD & A
2024-03-14 12:11C:HLS4.34SEDAR Annual Information FormSEDAR Annual Information Form
2024-03-14 12:11C:HLS4.34SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-14 10:25C:HLS3.99News ReleaseHLS Therapeutics loses $27.53M (U.S.) in fiscal 2023
2024-02-29 10:27C:HLS4.00News ReleaseHLS Therapeutics to release 2023 results March 14
2024-02-06 10:00C:HLS4.25News ReleaseHLS to list Vascepa under with B.C. drug plan